Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Buzz on the Bullboards: Of interest rates and rebates

Inflation continues to surge out of control to the point where grocery rebates seem to offer little help to struggling Canadians. This holiday-shortened week, markets are adjusting to the U.S. Federal Reserve’s move to raise interest rates. Investors a...
Jonathon Brown | July 6, 2023 |

Buzz on the Bullboards: Which stocks are turning inertia into momentum?

Markets have stumbled this week, especially tech indices as rising bond yields in the U.S. have had their way with the sector, which is sensitive to higher interest rates. One of the big updates of late, Datametrex AI Ltd. (TSXV:DM) brought investors up to spe...
Jonathon Brown | March 30, 2023 |

ACADIA Pharma's Shares Open 75% Higher on Positive Anti-Psychosis Drug Phase 3 Results

Shares of ACADIA Pharmaceuticals opened up 75% higher today after the company announced that its Phase 3 Study of pimavanserin for the treatment of dementia-related psychosis met its primary endpoint. San Diego, Calif.-based biopharmaceutical company ACADIA Pharmaceu...
Streetwise Reports | September 10, 2019 |

Mickey Fulp: Buy the Unknown, Unloved, Unwanted, Undervalued

Maurice Jackson: Joining us for conversation is Mickey Fulp, the world-renowned Mercenary Geologist . I want to speak to you today about the mainstream financial news networks and the narratives that they're pushing on both sides of the aisle, respectively. And of cou...
Streetwise Reports | June 4, 2020 |

Gold Leads, Will the Rest Follow?

The natural resource landscape has shifted dramatically since the end of 2018. At the time, we were still nursing our wounds from an unexpectedly vicious 2018 and hoping to avoid a repeat performance in 2019. I did speculate that "we may have already exited the bear mar...
Streetwise Reports | September 20, 2019 |

Reliq Re-establishes Itself as Community Care Technology Leader ...

Reliq Re-establishes Itself as Community Care Technology Leader Amidst Sweeping Federal Medicare/Medicaid Changes A shift in the industry leads to big new contracts and parabolic stock performance for this small cap. A sweeping new development in what federal...
Streetwise Reports | November 14, 2019 |

Buzz on the Bullboards: Top Talked About Stocks During Volatile Times

(Image via Tilray Inc.) A leading global cannabis-lifestyle and consumer packaged goods company, Tilray Inc. ( NASDAQ: TLRY , Forum ) has operations in Canada, the United States, Europe, Australia, and Latin America. SweetWater Brewing Company , a subsidiary o...
Stockhouse Editorial | March 1, 2022 |

Klondike Golden Moments

Foreword: This tale grew from a chance nugget discovery along the shore of a humble Yukon creek carving through the remote Territory and became the great history of the Klondike Gold Rush. Join author James Kwantes as he touches down in the Yukon with 12 exciting stories and c...
James Kwantes | August 15, 2019 |

The promise of AI

In ‘The Terminator’ series of action films starring Arnold Schwarzenegger, a cybernetic organism (cyborg) is programmed from the future to go back in time and kill the mother of the scientist who leads the fight against Skynet, an artificial intelligence syst...
Richard (Rick) Mills | November 22, 2019 |

Living in a virus-controlled world

As the coronavirus pandemic continues to infect populations, though in some countries it is slowing, talk has shifted to re-opening economies, and to manufacturing a vaccine that drug companies hope will not only work, but can be distributed at large enough doses to provide ...
Richard (Rick) Mills | April 24, 2020 |